Apyx Medical Corporation (APYX) Stock Overview
Explore Apyx Medical Corporation’s financial performance, market position, analyst ratings, and future outlook.
Apyx Medical Corporation (APYX)
Key Financials
Key Financials
Market Cap
128M
P/E Ratio
-14.61
EPS (TTM)
$-0.22
ROE
-0.79%
APYX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Apyx Medical Corporation (NASDAQ: APYX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Apyx Medical Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of APYX on the NASDAQ shows an RSI of 28.31, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $4.98 for the NASDAQ listing.
Key metrics behind Apyx Medical Corporation's NASDAQ-traded stock include a P/E ratio of -14.61 and a market capitalization of 128M. Combined with our AI analysis, these give both institutional and retail investors a clear view of APYX on the NASDAQ.